Background {#Sec1}
==========

Out-of-hospital cardiac arrest (OHCA) is a major public health challenge, with an average global incidence among adults of 55 OHCAs per 100,000 person-years. \[[@CR1]\] In China, there are more than 230 million people with cardiovascular disease, and 550,000 individuals experience cardiac arrest every year \[[@CR2]\]. Worldwide, survival after OHCA remains poor \[[@CR3]\]. In China, the survival rate of OHCA is less than 1% \[[@CR4]\]. Early initiation, good cardiopulmonary resuscitation (CPR) quality, and the use of an automated external defibrillator (AED) significantly improved survival and long-term outcomes in survivors of OHCA \[[@CR2], [@CR5]--[@CR7]\].

Many studies have been conducted to estimate the survival rate among OHCA patients who received CPR in different regions of the world \[[@CR4], [@CR8]--[@CR13]\]. However, the results were inconsistent across studies. The purpose of this systematic review and meta-analysis was to estimate the overall incidence of the return of spontaneous circulation (ROSC), the survival to admission rate, the survival to discharge rate, the 1-month survival rate, and the 1-year survival rate of patients after OHCA who received CPR worldwide.

Methods {#Sec2}
=======

This systematic review and meta-analysis adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines \[[@CR14]\] and the Meta-analysis of Observational Studies in Epidemiology (MOOSE) checklist \[[@CR15]\].

Search strategy {#Sec3}
---------------

Studies that reported survival rates among OHCA patients who underwent CPR were identified from the PubMed, Embase, and Web of Science databases from their inception to February 2019. The search terms were "out-of-hospital cardiac arrest" or "out-of-hospital ventricular fibrillation/ventricular tachycardia/asystole/pulseless electrical activity" or "cardiopulmonary resuscitation" or "CPR" or "mouth to mouth" or "resuscitation" or "resuscitation orders" or "survival" or "survival rate" or "mortality" or "sudden cardiac death". Only articles published in English were considered. Additionally, we manually reviewed the references listed in the retrieved articles to identify additional pertinent publications.

Inclusion criteria and exclusion criteria {#Sec4}
-----------------------------------------

Studies were included if they met the following eligibility criteria: (1) the study design was based on the Utstein-style reporting guidelines; (2) the study population was composed of adults, which included any study in which less than 20% of study population were pediatric patients (age \< 18 years); (3) the outcome variables were at least one of the following: ROSC, survival to admission rate, survival to hospital discharge rate, 1-month survival rate, and 1-year survival rate; (4) cardiac arrest happened outside the hospital; and (5) the study design was prospective, retrospective, or interventional. Reviews, letters, editorials, guidelines, and case reports were excluded. When multiple publications were produced using the same study population, the most recent and informative paper was included.

Data extraction {#Sec5}
---------------

Two independent reviewers (YG and NJ) performed the data extraction. The following data were extracted from the studies: the first author's name, region of population, year of publication, sex, number of cardiac arrests and survivors, cardiac arrest witness type, provision of CPR, and origin of cardiac arrest. The rate of survival to hospital discharge was considered the primary outcome; ROSC, the rate of survival to hospital admission, 1-month survival rate and 1-year survival rate were also analyzed as outcome variables. Any disagreements between the investigators were discussed, and an agreement was reached through consensus.

Statistical analysis {#Sec6}
--------------------

A random-effects model was used to estimate the survival rates among OHCA patients who received CPR \[[@CR16]\]. Studies that reported the survival outcomes of OHCA patients who received CPR (ROSC, survival to admission rate, survival to discharge rate, 1-month survival rate, and 1-year survival rate) were treated as independent reports.

Statistical heterogeneity across studies was assessed with the *I*^*2*^ statistic, where values of 25%, 50%, and 75% represented the cut-off points for low, moderate, and high levels of heterogeneity, respectively \[[@CR17]\]. Publication bias was evaluated with funnel plots and Egger's test \[[@CR18]\]. Subgroup analyses stratified by sex, study location, study period, origin of OHCA, CPR type, and cardiac arrest witness type were conducted to investigate potential sources of heterogeneity across subgroups and examine the robustness of the primary results. We performed sensitivity analyses by omitting one study at a time to assess the influence of any single study on the pooled survival rate estimates. All statistical analyses were conducted with STATA V.12.0 (StataCorp, College Station, TX). All tests were two-tailed with a significance level of 0.05.

Results {#Sec7}
=======

Study selection {#Sec8}
---------------

The process of study selection, identification, and inclusion using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram is presented in Fig. [1](#Fig1){ref-type="fig"}. Initially, 5502 articles were retrieved from the PubMed, Embase, and Web of Science databases. In addition, we identified 13 articles by manually searching the reference lists of the retrieved articles. After removing 915 duplicate articles, we further excluded 4371 articles based on the titles and abstracts, including 336 nonhuman studies and 280 reviews, editorials, letters, guidelines or case reports. A total of 229 articles were selected for further full texts assessment. After retrieving the full-text for evaluation in detail, 88 articles were excluded because their study populations were pediatric patients, their primary outcome focused on the neurological survival rate or they were multiple publications produced using the same study population. Finally, a total of 141 studies were included in the present meta-analysis. The references of the studies included in the meta-analysis are listed in the Additional file [1](#MOESM1){ref-type="media"}. Fig. 1Flow chart of relevant study identification in relation to outcomes of OHCA who underwent CPR

Characteristics and quality of the studies included {#Sec9}
---------------------------------------------------

The characteristics of the 141 included studies are shown in Supplementary Table [1](#MOESM1){ref-type="media"}. These studies were conducted on 4 continents. Fifty-six studies were conducted in Europe, 48 in North America, 29 in Asia, 6 in Oceania, and two in both Europe and North America. A total of 31 studies reported the survivors and study population stratified by sex. The year of publication ranged from 1976 to 2019. In total, 4,610,669 OHCA patients who underwent CPR were involved in this study. We included 62 studies that reported the incidence of ROSC, 88 studies that explored the rate of survival to admission, 103 studies that assessed the rate of survival to discharge, 33 studies that investigated the 1-month survival rate, and 22 studies that reported the 1-year survival rate. Nineteen studies included pediatric patients, but less than 20% of study population was younger than 18 years.

ROSC {#Sec10}
----

In this study, 62 studies with 74 reports reported the outcome of ROSC in OHCA patients who underwent CPR. From the random-effects meta-analysis, we found that the pooled incidence of ROSC among OHCA patients was 29.7% (95% CI, 27.6--31.7%) with significant heterogeneity across studies (*I*^2^ = 99.9%, *P* \< 0.001).

Subgroup analyses showed significant differences in the incidence of prehospital ROSC by study location, the provider of CPR, and study period (Table [1](#Tab1){ref-type="table"}). With regard to study location, Oceania had the highest incidence of ROSC (38.6%; 95% CI 22.9--54.2%), followed by Europe (36.7%; 95% CI 32.4--40.9%). Asia had the lowest incidence of ROSC (22.1%; 95% CI 18.1--26.0%). Regarding the provider of CPR, the incidence of ROSC was the highest among OHCA patients who had received CPR from emergency medical services (EMS) (36.3%; 95% CI 23.8--48.9%). Table 1The incidence of ROSC, survival to admission, survival to discharge, 1 month survival, and 1 year survival: the overall estimates and subgroup analysesNo. of reportsSurvivorsOHCA casesProportion (%)95%CI*I*^2^*P* value for heterogeneity**ROSC\*74203,0841,560,83029.727.6 to 31.799.90%\< 0.001Sex** Men224285628.924.2 to 33.643.4%0.184 Women215147831.627.4 to 35.80.00%0.542 Combined70202,6911,559,49629.727.6 to 31.899.90%\< 0.001**Study location** Europe32416612,27436.732.4 to 40.996.10%\< 0.001 Asia17186,0601,500,11022.118.1 to 26.0100.00%\< 0.001 North America20698132,52024.319.7 to 28.999.10%\< 0.001 Oceania5587715,92638.622.9 to 54.299.20%\< 0.001**Study period** 1976--199925370615,42934.228.0 to 40.498.70%\< 0.001 2000--200930409117,15928.323.9 to 32.798.00%\< 0.001 2010--201919195,2871,528,24227.523.6 to 31.3100.00%\< 0.001**CPR type** Bystander CPR17138,149863,97826.320.9 to 31.8100.00%\< 0.001 EMS CPR1545,505624,49636.323.8 to 48.999.50%\< 0.001 Unspecific CPR4219,43072,35629.625.9 to 33.399.30%\< 0.001**Origin of OHCA** Cardiac etiology4930,531143,83133.930.1 to 37.799.50%\< 0.001 Non-traumatic14765233,31821.516.2 to 26.899.20%\< 0.001 All patients11164,9011,383,68123.318.3 to 28.3100.00%\< 0.001 OthersNANANANANANANA**Witnessed type** Witnessed31106,894440,28136.430.6 to 42.299.90%\< 0.001 Not witnessed1349336.626.8 to 46.40.00%\< 0.001 Mixed3695,8281,119,24823.722.2 to 25.399.80%\< 0.001 Unspecific events6328120828.218.6 to 37.791.30%\< 0.001**Survival to admission**†**12255,026377,72722.020.7 to 23.499.4%\< 0.001Sex** Men7564282920.316.3 to 24.381.00%\< 0.001 Women7254102123.417.8 to 29.172.60%\< 0.001 Combined10854,208373,87722.120.6 to 23.599.40%\< 0.001**Study location** Europe5220,987123,02425.723.9 to 27.698.30%\< 0.001 Asia2723,551203,28315.613.2 to 18.099.70%\< 0.001 North America39550435,18320.518.1 to 22.997.50%\< 0.001 Oceania4498416,23733.521.7 to 45.398.90%\< 0.001**Study period** 1976--199959570433,08322.420.0 to 24.897.30%\< 0.001 2000--20093818,433106,33625.122.9 to 27.398.50%\< 0.001 2010--20192530,889238,30817.214.4 to 19.999.80%\< 0.001**CPR type** Bystander CPR21666044,02822.818.8 to 26.899.10%\< 0.001 EMS CPR232043765725.519.7 to 31.297.40%\< 0.001 Unspecific CPR7846,323326,04221.119.5 to 22.799.50%\< 0.001**Origin of OHCA** Cardiac etiology6622,682143,61223.521.2 to 25.999.50%\< 0.001 Non-traumatic3817,293142,53219.317.5 to 21.298.60%\< 0.001 All patients1113,95386,44320.417.1 to 23.799.10%\< 0.001 Others71098514023.619.4 to 27.791.50%\< 0.001**Witnessed type** Witnessed3712,02788,99223.220.3 to 26.199.60%\< 0.001 Not witnessed1239324.715.9 to 33.50.00%\< 0.001 Mixed7542,630286,47021.620.1 to 23.199.10%\< 0.001 Unspecific events9346217219.214.5 to 23.984.30%\< 0.001**Survival to discharge**^**‡**^**16820,946267,8628.88.2 to 9.497.60%\< 0.001Sex** Men22157626,6667.46.2 to 8.793.60%\< 0.001 Women2172313,5707.25.6 to 8.791.70%\< 0.001 Combined12518,647227,6269.38.5 to 10.097.90%\< 0.001**Study location** Europe59360733,67311.710.5 to 13.092.70%\< 0.001 Asia16532986,3334.53.1 to 5.998.60%\< 0.001 North America8910,115131,5647.76.9 to 8.697.60%\< 0.001 Oceania4189516,29216.25.9 to 26.599.10%\< 0.001**Study period** 1976--199980485159,8168.67.7 to 9.595.00%\< 0.001 2000--200963561278,0188.67.5 to 9.697.20%\< 0.001 2010--20192510,483130,0289.98.4 to 11.499.10%\< 0.001**CPR type** Bystander CPR35449339,97411.39.3 to 13.297.40%\< 0.001 EMS CPR27175414,10810.78.2 to 13.295.80%\< 0.001 Unspecific CPR10614,699213,7807.77.0 to 8.397.40%\< 0.001**Origin of OHCA** Cardiac etiology8411,765132,29210.09.1 to 10.997.00%\< 0.001 Non-traumatic627117111,1717.06.2 to 7.997.70%\< 0.001 All patients1387998268.35.4 to 11.296.00%\< 0.001 Others9118514,57310.18.3 to 12.089.50%\< 0.001**Witnessed type** Witnessed44896797,06910.59.2 to 11.797.60%\< 0.001 Not witnessed3163244.41.4 to 7.440.00%0.189 Mixed11811,951170,3418.27.5 to 8.997.20%\< 0.001 Unspecific events3121288.94.0 to 13.80.00%0.705**One-month survival**^§^**54247,9992,362,22310.79.1 to 12.399.9%\< 0.001Sex** Men4396846,8318.05.2 to 10.999.10%\< 0.001 Women4247718,8919.53.2 to 15.899.50%\< 0.001 Combined45241,5542,296,50111.09.3 to 12.8100%\< 0.001**Study location** Europe2825,371292,4739.07.6 to 10.399.50%\< 0.001 Asia21222,2852,066,70512.810.0 to 15.5100%\< 0.001 North America2416236.54.6 to 8.50.00%0.415 Oceania3302242216.08.4 to 23.796.10%\< 0.001**Study period** 1976--1999NANANANANANANA 2000--20092817,304219,9658.06.7 to 9.399.3%\< 0.001 2010--201926230,6952,142,25813.310.9 to 15.7100%\< 0.001**CPR type** Bystander CPR25161,3861,074,76712.89.0 to 16.7100%\< 0.001 EMS CPR637,308666,66912.38.6 to 16.099.70%\< 0.001 Unspecific CPR2349,305620,7877.97.1 to 8.799.20%\< 0.001**Origin of OHCA** Cardiac etiology2621,262208,63110.59.1 to 12.099.10%\< 0.001 Non-traumatic1233426.74.1 to 9.30\< 0.001 All patients27226,7142,153,25010.88.5 to 13.1100%\< 0.001 OthersNANANANANANANA**Witnessed type** Witnessed27169,5421,055,93513.210.3 to 16.199.9%\< 0.001 Not witnessedNANANANANANANA Mixed2778,4571,306,2888.37.4 to 9.199.7%\< 0.001 Unspecific eventsNANANANANANANA**One-year survival**¶**27379142,0277.75.8 to 9.597.5%\< 0.001Sex** Men1133204.11.9 to 6.30.00%\< 0.001 Women1142196.43.2 to 9.60.00%\< 0.001 Combined25376441,4887.95.9 to 9.897.7%\< 0.001**Study location** Europe16337835,6049.26.4 to 12.098.2%\< 0.001 Asia311825045.32.7 to 8.087.8%\< 0.001 North America79621904.02.8 to 5.351.2%0.056 Oceania1199172911.510.0 to 13.00.0%\< 0.001**Study period** 1976--19991040735178.54.1 to 12.896.6%\< 0.001 2000--20091447974966.04.3 to 7.689.0%\< 0.001 2010--20193290531,01412.35.4 to 19.399.6%\< 0.001**CPR type** Bystander CPR2157910,80512.36.4 to 18.179.6%0.027 EMS CPR3174803.20.5 to 6.064.6%0.059 Unspecific CPR22219530,7427.66.1 to 9.295.2%\< 0.001**Origin of OHCA** Cardiac etiology25376341,4937.96.0 to 9.997.6%\< 0.001 Non-traumatic1243387.14.4 to 9.80.0%\< 0.001 All patientsNANANANANANANA Others141962.00 to 4.00.0%\< 0.001**Witnessed type** Witnessed1228357655.34.0 to 6.577.9%\< 0.001 Not witnessedNANANANANANANA Mixed15350836,2629.06.1 to 11.998.3%\< 0.001 Unspecific eventsNANANANANANANANote: *CI* confidence interval, *CPR* cardiopulmonary resuscitation, *EMS* emergency medical services, *NA* not available, *OHCA* out-of-hospital cardiac arrests, *ROSC* return of spontaneous circulation\*Two studies reported their results by study location, 2 studies reported their results by sex, 4 studies reported their results by CPR type, 2 studies reported their results by witness type, and 1 study reported their results by OHCA type; therefore, there were 74 reports from 62 studies†Four studies reported their results by study location, 7 studies reported their results by sex, 7 studies reported their results by CPR type, 2 studies reported their results by witness type, and 1 study reported their results by OHCA type; therefore, there were 122 reports from 88 studies^**‡**^Three studies reported their results by study location, 21 studies reported their results by sex, 16 studies reported their results by CPR type, 1 study reported their results by witness type, and 2 studies reported their results by OHCA type; therefore, there were 168 reports from 103 studies^§^Four studies reported their results by sex, 4 studies reported their results by CPR type, 2 studies reported their results by OHCA type, and 1 study reported their results by year; therefore, there were 54 reports from 33 studies¶One study reported their results by sex, 2 studies reported their results by CPR type, and 1 study reported their results by witness type; therefore, there were 27 reports from 22 studies

Survival to admission {#Sec11}
---------------------

A total of 88 studies with 122 reports estimated the incidence of survival to admission of OHCA patients who underwent CPR. From the random-effects meta-analysis, an incidence of 22.0% (95% CI 20.7--23.4%) for survival to admission was estimated globally among OHCA patients who received CPR.

With regard to study location, Oceania had the highest incidence (33.5%; 95% CI 21.7--45.3%), followed by Europe (25.7%; 95% CI 23.9--27.6%), North America (20.5%; 95% CI 18.1--22.9%), and Asian countries (15.6%; 95% CI 13.2--18.0%).

Survival to discharge {#Sec12}
---------------------

One hundred and three studies with 168 reports investigated the rate of survival to discharge of OHCA patients who underwent CPR. From the random-effects meta-analysis, an incidence of 8.8% (95% CI 8.2--9.4%) for survival to discharge was estimated globally among OHCA patients, and there was high heterogeneity across studies (*P* \< 0.001; *I*^*2*^ = 97.6%) (Table [1](#Tab1){ref-type="table"}). The rate of survival to discharge of OHCA patients who received CPR increased from 8.6% (95% CI 7.7--9.5%) in 1976--1999 to 9.9% (95% CI 8.4--11.4%) in 2010--2019.

Subgroup analyses showed significant differences in the survival rate by study location and provider of CPR. Across the study locations, Oceania had the highest survival rate (16.2%; 95% CI 5.9--26.5%), followed by Europe (11.7%; 95% CI 10.5--13.0%), North America (7.7%; 95% CI 6.9--8.6%), and Asia (4.5%; 95% CI 3.1--5.9%). Regarding the provider of CPR, the survival rate was relatively higher among patients who received bystander CPR (11.3%; 95% CI 9.3--13.2%).

One-month survival rate {#Sec13}
-----------------------

In total, 33 studies with 54 reports investigated the 1 month survival rate of OHCA patients who underwent CPR. From the random-effects meta-analysis, an incidence of 10.7% (95% CI 9.1--12.3%) for 1-month survival was estimated globally among OHCA patients who had received CPR, and there was high heterogeneity among the studies (*P* \< 0.001; *I*^*2*^ = 99.9%).

Subgroup analyses showed significant differences in 1-month survival by study location and study period. Across the study locations, Oceania had the highest survival rate (16.0%; 95% CI 8.4--23.7%), followed by Asia (12.8%; 95% CI 10.0--15.5%), Europe (9.0%; 95% CI 7.6--10.3%), and North America (6.5%; 95% CI 4.6--8.5%). Across the study periods, the 1-month survival rate increased from 8.0% (95% CI, 6.7--9.3%) in 2000--2009 to 13.3% (95% CI 10.9--15.7%) in 2010--2019.

One-year survival rate {#Sec14}
----------------------

Twenty-seven reports from 22 studies investigated the 1 year survival rate of OHCA patients who underwent CPR. From the random-effects meta-analysis, an incidence of 7.7% (95% CI 5.8--9.5%) for 1-year survival was estimated globally among OHCA patients who received CPR, and there was high heterogeneity among the studies (*P* \< 0.001; *I*^*2*^ = 97.5%).

Subgroup analyses showed significant differences in 1-year survival by study location and study period. Across the study locations, Oceania had the highest survival rate (11.5%; 95% CI 10.0--13.0%), followed by Europe (9.2%; 95% CI 6.4--12.0%), Asia (5.3%; 95% CI 2.7--8.0%), and North America (4.0%; 95% CI 2.8--5.3%). Across the study periods, the 1-year survival rate increased from 6.0% (95% CI 4.3--7.6%) in 2000--2009 to 12.3% (95% CI 5.4--19.3%) in 2010--2019. Regarding the provider of CPR, the survival rate was relatively higher among patients who received bystander CPR (12.3%; 95% CI 6.4--18.1%).

Sensitivity analyses {#Sec15}
--------------------

The exclusion of studies with sample sizes less than 100 yielded pooled incidences of 29.0% (95% CI 26.8--31.2%, *P* \< 0.001), 21.6% (95% CI 20.1--23.0%, *P* \< 0.001), 8.6% (95% CI 8.0--9.2%, *P* \< 0.001), 10.8% (95% CI 9.2--12.4%, *P* \< 0.001), and 7.6% (95% CI 5.7--9.5%, *P* \< 0.001) for ROSC, survival to hospital admission, survival to hospital discharge, 1-month survival, and 1-year survival, respectively. Thus, the survival rate did not change significantly when the observations with sample sizes less than 100 were excluded, which indicated that studies with small sample sizes did not influence the overall result. Furthermore, after the exclusion of these studies (*n* = 19) including pediatric patients, the pooled survival rates for ROSC, survival to hospital admission, survival to hospital discharge, 1-month survival, and 1-year survival were 30.5% (95% CI 26.7--34.3%, *P* \< 0.001), 21.8% (95% CI 20.4--23.3%, *P* \< 0.001), 9.7% (95% CI 8.9--10.5%, *P* \< 0.001), 10.1% (95% CI 7.9--12.3%, *P* \< 0.001), and 7.6% (95% CI 5.6--9.6%, *P* \< 0.001), respectively.

Sensitivity analyses were performed by omitting each study in turn and combining the results of the remaining included studies. The overall summary survival rates for ROSC, survival to admission, survival to discharge, and the 1-month and 1-year survival rates did not alter substantially. The pooled survival rates derived from the sensitivity analyses for ROSC ranged from 28.8% (95% CI 27.5--30.1%) to 30.3% (95% CI 27.6--33.0%), those for survival to hospital admission ranged from 21.7% (95% CI 20.4--23.1%) to 22.2% (95% CI 20.8--23.7%), those for survival to hospital discharge ranged from 8.6% (95% CI 8.0--9.2%) to 8.9% (95% CI 8.2--9.5%), those for 1-month survival ranged from 10.1% (95% CI 8.5--11.7%) to 10.9% (95% CI 9.3--12.4%), and those for 1-year survival ranged from 6.9% (95% CI 5.2--8.6%) to 7.9% (95% CI 6.0--9.8%).

Publication bias {#Sec16}
----------------

The funnel plot was symmetrical for the meta-analysis of the incidence of ROSC, survival to hospital admission, survival to hospital discharge, 1-month survival, and 1-year survival in OHCA patients who received CPR (see Figs. [2](#Fig2){ref-type="fig"}, [3](#Fig3){ref-type="fig"}, [4](#Fig4){ref-type="fig"}, [5](#Fig5){ref-type="fig"}, and [6](#Fig6){ref-type="fig"}). The Egger's test revealed no evidence of publication bias among the studies that reported the incidence of ROSC, survival to admission, survival to hospital discharge, and 1-year survival rate (Egger's *P* = 0.362 for ROSC; Egger's *P* = 0.128 for survival to admission; Egger's *P* = 0.112 for survival to hospital discharge; Egger's *P* = 0.168 for 1-year survival). However, for the 1-month survival among OHCA patients who underwent CPR, we found that Egger's test revealed evidence of publication bias across studies (Egger's *P* \< 0.05). Fig. 2Funnel plot for the incidence of ROSC among OHCA patients who underwent CPR Fig. 3Funnel plot for the incidence of survival to admission among OHCA patients who underwent CPR Fig. 4Funnel plot for the incidence of survival to discharge among OHCA patients who underwent CPR Fig. 5Funnel plot for the 1 month survival rate among OHCA patients who underwent CPR Fig. 6Funnel plot for the 1 year survival rate among OHCA patients who underwent CPR

Discussion {#Sec17}
==========

This is the first comprehensive systematic review and meta-analysis bringing together 40 years of research to estimate the incidence of ROSC, rate of survival to admission, rate of survival to discharge, 1-month survival rate, and 1-year survival rate among OHCA patients who received CPR worldwide. We found that the pooled incidence of ROSC, and survival to admission, survival to discharge, 1-month survival, and 1-year survival rates were 29.7%, 22.0%, 8.8%, 10.7%, and 7.7%, respectively. In addition, much lower rates of the incidence of ROSC, survival to admission, and survival to discharge were observed across Asian countries and much higher survival to discharge, 1-month survival, and 1-year survival rates were found among OHCA patients who had received bystander CPR. Finally, survival to discharge among OHCA patients who underwent CPR significantly improved over the 40-year period.

Two previous studies published in 2010 \[[@CR19]\] and 2013 \[[@CR20]\] investigated the survival rate of OHCA patients who received CPR. The results of this current meta-analysis generally concur and further complement the findings of a previous review in several important aspects. Van de Glind et al. \[[@CR20]\] reported that the pooled survival to discharge among patients \> 70 years of age was 4.1% (95% CI 3.0--5.6%), which was lower than that in the present study (8.8%: 95% CI 8.2--9.4%). One possible reason was that there were differences in the study population and sample size. The review by Van de Glind and colleagues included only 23 studies among older patients aged \> 70 years. However, our study population included all age groups. Several studies showed that increasing age was significantly associated with worse survival \[[@CR21]--[@CR23]\]. Additionally, their review did not fully investigate other subgroups or perform sensitivity analyses. Sasson et al. \[[@CR19]\] found that the pooled survival to hospital discharge rate was 7.6% (95% CI 6.7--8.4%). However, 62 studies were not included in their analysis because their search time was limited to 2008, which may have led to overestimation of the survival rate. In addition, our review performed more detailed subgroup analyses (stratified by sex, study location, study period, type of OHCA, type of CPR, and type of cardiac arrest witness) to test the robustness of the results and explore the potential heterogeneity.

Our subgroup analyses led to two valuable findings. First, much lower rates of ROSC, survival to admission, and survival to discharge were observed in Asian countries than in European counties. These observed differences may in part reflect the differences in first registered arrhythmia as VT/VF, witnessed collapse, bystander CPR, and early defibrillation in various countries \[[@CR4], [@CR24]\]. These factors were significantly associated with the survival rates of OHCA patients \[[@CR25]--[@CR27]\]. Another explanation is that compared with North America and Europe, and the popularization of bystander CPR has been relatively delayed in Asia; thus, the quality of bystander CPR might be lower in Asia. In addition, a previous study showed that the thresholds of EMS protocols for initiating resuscitation are lower in Asian countries, \[[@CR1]\] which was likely to contribute to the differences in the survival rates.

We also found much higher rates of survival to discharge, 1 month survival, and 1 year survival among OHCA patients who received bystander CPR, which was consistent with the findings of previous studies \[[@CR26], [@CR28]--[@CR30]\]. This suggests that efforts, such as targeted CPR training to increase the bystander CPR rate, will have a substantial effect on improving the survival rates after OHCA \[[@CR6], [@CR31]\]. Thus, facilitating bystander CPR training is an important and effective measure that governments worldwide can implement to improve the outcome of OHCA patients.

Strengths and limitations {#Sec18}
-------------------------

The present study has several strengths. First, this is the first study to date investigating the survival of OHCA patients worldwide. Second, based on the subgroup analysis, we showed that the survival to discharge rate was much lower in developing countries than in developed counties, and the ROSC and survival to discharge rates were decreasing. Finally, as the incidence of OHCA is increasing in modern society, the results of our study can not only serve as baseline data for the global assessment of OHCA prevention interventions (evidence-based region-specific guideline updates of CPR for OHCA) but also provide a reference for international comparisons.

Potential limitations in this study need to be acknowledged. A high degree of heterogeneity was observed in this meta-analysis. The heterogeneity across studies may result from differences in the EMS system, research method, samples, provider and quality of CPR (e.g., bystander CPR, EMS CPR), and Utstein definition. However, the sensitivity analyses and consistent results from various subgroup analyses suggested that the estimates were relatively robust, and the heterogeneity can be overestimated when studies with large sample sizes are pooled. Second, only those studies published in English were included in this meta-analysis and studies in other languages were omitted. Third, the literature searches were carried out in three databases, which may be considered a source of bias.

Suggestions for further research {#Sec19}
--------------------------------

More effort should be put into future research. First, more studies should be included to explore the predictors of survival of OHCA and investigate the associations between survival after OHCA and the predictors (age, sex, location of cardiac arrest, response time, CPR by bystander or EMS-physician-guided CPR, AED utilization). This would help elucidate the reasons for improved survival and the underlying mechanisms. Second, investigating the quality of life and cognitive and functional changes in survivors after OHCA will be valuable. Finally, more studies validating the cost-effectiveness of bystander CPR training or AED utilization are warranted.

Conclusion {#Sec20}
==========

In conclusion, this meta-analysis suggests that the rates of survival to discharge, 1 month survival, and 1 year survival are increasing among OHCA patients who receive CPR globally. Relatively lower survival to discharge rates were observed in Asian countries. Higher rates of survival to discharge, 1-month survival, and 1-year survival were found among OHCA patients who had their cardiac arrest witnessed by EMS or a bystander and who received bystander CPR.

Supplementary information
=========================

 {#Sec21}

Additional file 1:**Table S1.** Characteristics of included studies. Supplementary references.

AED

:   Automated external defibrillator

CI

:   Confidence interval

CPR

:   Cardiopulmonary resuscitation

EMS

:   Emergency medical services

OHCA

:   Out-of-hospital cardiac arrests

ROSC

:   Return of spontaneous circulation
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